Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2010
03/24/2010EP2164861A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin
03/24/2010EP2164859A2 Methods and compositions involving polymeric immunoglobulin fusion proteins
03/24/2010EP2164519A2 Long-acting polymeric prodrugs of exendin
03/24/2010EP1801206B1 Method for producing l-arginine, l-ornithine or l-citrulline
03/24/2010EP1755660B1 Method for enhancing or inhibiting insulin-like growth factor-i
03/24/2010EP1697403B1 Haemophilus influenzae type iv pili
03/24/2010EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease
03/24/2010EP1067962B1 Derivatives of pneumococcal choline binding proteins for vaccines
03/24/2010CN101680902A Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
03/24/2010CN101680901A Diagnosis of collagen IX destruction
03/24/2010CN101680887A Method of determining risk of scoliosis
03/24/2010CN101680031A Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same
03/24/2010CN101680014A glycosylation of molecules
03/24/2010CN101679992A Expression system
03/24/2010CN101679989A Methods and compositions for enhanced protein expression and purification
03/24/2010CN101679988A Fusion proteins binding to growth factors
03/24/2010CN101679984A Rumc peptides with antimicrobial activity
03/24/2010CN101679981A Mutant plant and method for production thereof
03/24/2010CN101679980A variant activin receptor polypeptides and uses thereof
03/24/2010CN101679975A proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders
03/24/2010CN101679969A Method for producing rice plant resistant to rice dwarf virus by RNA interference
03/24/2010CN101679968A Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof
03/24/2010CN101679953A Mutant reoviruses and methods of making and using
03/24/2010CN101679941A Use of copper and glutamate in cell culture for production of polypeptides
03/24/2010CN101679516A Antigen-binding proteins targeting s. aureus ORF0657
03/24/2010CN101679505A Variants derived from actriib and uses therefor
03/24/2010CN101679504A Growth hormone fusion proteins
03/24/2010CN101679503A transglutaminase variants with improved specificity
03/24/2010CN101679502A A new type of consensus interferon and preparation method thereof
03/24/2010CN101679501A methods of treating, diagnosing and detecting fgf21-associated disorders
03/24/2010CN101679500A G-protein-conjugated receptor having altered ligand affinity, and use thereof
03/24/2010CN101679499A Anti-tumor drug, medicament, composition, and use thereof
03/24/2010CN101679498A bis-met histones
03/24/2010CN101679497A Soluble Il-17RA/RC fusion proteins and related methods
03/24/2010CN101679496A Method for producing mature vwf from vwf pro-peptide
03/24/2010CN101679495A Short bio-active peptides for cellular and immunological modulation
03/24/2010CN101679494A Methods of increasing plant growth
03/24/2010CN101679493A Yield enhancement in plants by modulation of maize alfins
03/24/2010CN101679492A A functional r-gene from solanum bulbocastanum
03/24/2010CN101679491A insecticidal proteins
03/24/2010CN101679490A Increased production of a target product via stabilization of mRNA
03/24/2010CN101679489A A modified secretion system to increase expression of polypeptides in bacteria
03/24/2010CN101679475A Improved vaccines and methods for using the same
03/24/2010CN101678104A New indications for anti- il-i-beta therapy
03/24/2010CN101678091A Lyophilised antigen composition
03/24/2010CN101678088A Modified mutant collagenase and it's use in fat melting and in scar reduction
03/24/2010CN101678084A Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
03/24/2010CN101678079A Modified erythropoietin polypeptides and uses thereof for treatment
03/24/2010CN101678076A Use of the augmenter of liver regeneration protein as an apoptosis regulator
03/24/2010CN101678068A Treating stroke and other diseases without inhibiting n-type calcium channels
03/24/2010CN101677537A disintegrin variants and pharmaceutical uses thereof
03/24/2010CN101676728A cytokine receptor
03/24/2010CN101676400A Expression of biologically active polypeptides in duckweed
03/24/2010CN101676389A Modified vaccinia ankara virus variant
03/24/2010CN101676299A Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
03/24/2010CN101675993A melan-a peptide analogue-virus-like-particle conjugates
03/24/2010CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine
03/24/2010CN100595275C Immortalized preosteoblasts and method for their production
03/24/2010CN100595210C Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof.
03/24/2010CN100595209C PH-dependent polypeptide aggregation and its use
03/24/2010CN100594932C Tumor necrosis factor antagonists and their use in endometriosis
03/23/2010US7683238 Preparing transgenic plants for use as bioreactors in generation of therapeutic proteins; pharmacogenetics
03/23/2010US7683159 Tenascin-W compositions and uses thereof
03/23/2010US7683158 Proteinaceous construct comprising a Factor VIII molecule conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII; for prolonging in vivo-half-life of FVIII in the blood of a mammal having a bleeding disorder associated with functional defects or deficiencies of FVIII
03/23/2010US7683033 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
03/23/2010US7683032 for treatment of infectious and inflammatory diseases, female fertility disorders, autoimmune disorders, tumors
03/23/2010US7683031 for stimulation of angiogenesis
03/23/2010US7683030 Methods of treating diabetes with albumin-conjugated exendin peptides
03/23/2010US7682789 Method for quantifying biomolecules conjugated to a nanoparticle
03/23/2010US7682618 Generation of virus-like particles and use as panfilovirus vaccine
03/23/2010US7682607 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
03/23/2010CA2482865C Device for mixing and/or injecting cements
03/23/2010CA2425321C Plant cell death system
03/23/2010CA2356737C Tumor necrosis factor antagonists and their use in endometriosis
03/23/2010CA2353523C Allo and auto-reactive t-cell epitopes
03/23/2010CA2305312C Mammalian genes involved in viral infection and tumor suppression
03/23/2010CA2283535C Glycine transporter
03/23/2010CA2236168C Disruption of expression of multiple alleles of mammalian genes
03/23/2010CA2223412C Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
03/23/2010CA2203655C Tumor necrosis factor-gamma
03/23/2010CA2172906C Biocompatible adhesive compositions
03/18/2010WO2010030992A2 Novel plasmodium falciparum gene encoding signal peptide peptidase and methods of using inhibitors thereof for inhibiting malarial infection
03/18/2010WO2010030840A2 Novel receptor and uses thereof
03/18/2010WO2010030671A1 Type i interferon antagonists
03/18/2010WO2010030653A2 Nurr1 interacting protein (nuip)
03/18/2010WO2010030244A1 A heparan sulphate which binds bmp2
03/18/2010WO2010030140A2 A prokaryotic expansin protein for activating cellulose expansion and cellulose-degrading composition comprising the same
03/18/2010WO2010029610A1 Hybrid alpha-glucoside transporter
03/18/2010WO2010029363A2 Peptide and uses thereof
03/18/2010WO2010029317A2 Treating inflammatory conditions
03/18/2010WO2010029311A2 Herbicide tolerant plants
03/18/2010WO2010029297A1 Photo-ionic pacemakers
03/18/2010WO2010029293A1 Non-typhoidal salmonella vaccines
03/18/2010WO2010029278A2 Isolation and identification of glycosaminoglycans
03/18/2010WO2010029159A1 Method of acylating a peptide or protein
03/18/2010WO2010029130A1 Neuronal viability factor and use thereof
03/18/2010WO2010029107A1 Growth hormone conjugate with increased stability
03/18/2010WO2010028999A2 Production of infectious hepatitis c virus particles in cell culture
03/18/2010WO2010028849A1 Attenuated liver-stage plasmodium and vaccine containing the same
03/18/2010WO2010011907A3 Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof
1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 2916